Farmas USA

a ti si, que vas con BK y es banco patrio, pero los que llevabamos brokers extranjeros ...

NVAX

Escalando otra vez.

PTCT ya ha roto los 8 pavos.

PTX,0,47,,todavia ando pillado a 0,49.

TTPH poco a poco ya esta en 4,25.

Estoy en verdeeeeeeeeee!!! Oeoeoeoeoeoe!!!
NVAX

Nvax
A mí solo me falta un pavo
!!biennnnnn!! Jajaja

http://247wallst.com/healthcare-business/2016/05/23/10-speculative-biotech-and-biohealth-stocks-with-massive-analyst-upside-calls/

Amarin

Amarin Corp. (NASDAQ: AMRN) was assumed with a Buy rating and a $3.50 price target (versus a $1.57 prior close) at Jefferies on May 12. The firm said it believes that the off-label Vascepa promotion in mixed dyslipidemia may be starting to bear fruit. It said:

We believe off-label Vascepa promotion in mixed dyslipidemia may be beginning to bear fruit, where our analysis of TRx data suggests a steeper upward trend in recent months v. 2015. Access to this population is a major source of upside, where we see opportunity of $2.5 billion. Focus is also on REDUCE-IT where we believe Vascepa can show a benefit on final analysis in early 2018, and upside could be $14 per share.

Read more: 10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls - Amarin Corp plc (ADR) (NASDAQ:AMRN) - 24/7 Wall St. http://247wallst.com/healthcare-business/2016/05/23/10-speculative-biotech-and-biohealth-stocks-with-massive-analyst-upside-calls/#ixzz49bHOVIGF
Follow us: @247wallst on Twitter | 247wallst on Facebook

Como estan peleando los 5,5, no quieren ... Malditos!

NVAX

Que aguanten, que aguanten que mañana vendrá el mini tsunami con Stan

Nvax